Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.

The oncologist - 2 Jun 2023

Crowley Fionnuala, Gandhi Sonal, Rudshteyn Michelle, Sehmbhi Mantej, Cohen Deirdre J

Abstract excerpt

INTRODUCTION: National Comprehensive Cancer Network (NCCN) 2019 Guidelines recommend universal germline (GL) testing for patients (pts) with pancreatic cancer (PC), given germline mutations (gMut) can occur at a similar rate irrespective of an individual's family history of cancer. Molecular analysis of tumors in those with metastatic disease is also recommended. We aimed to determine rates of genetic testing at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36933202
DOI: 10.1093/oncolo/oyad044
PMCID: PMC10243789

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.PMID 36933202Read ↗

Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain.Semantic proximity Read ↗

Impact of changing guidelines on genetic testing and surveillance recommendations in a contemporary cohort of breast cancer survivors with family history of pancreatic cancer.Semantic proximity Read ↗

Impact of Changing Guidelines on Genetic Testing and Surveillance Recommendations in a Contemporary Cohort of Breast Cancer Survivors with Family History of Pancreatic CancerSemantic proximity Read ↗

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.Semantic proximity Read ↗

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.Semantic proximity Read ↗

Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.Semantic proximity Read ↗

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.Semantic proximity Read ↗

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.Semantic proximity Read ↗

Genomic testing for pancreatic cancer in clinical practice as real-world evidenceSemantic proximity Read ↗

Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.Semantic proximity Read ↗

Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.Semantic proximity Read ↗

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.